This session from TMA's 2019 Annual Patient Conference in Minneapolis offers an update on myositis clinical trials from the pharmaceutical company perspective. Learn how pharmaceutical companies choose their research projects, identify research sites, and coordinate with researchers and those affected by disease. Learn about the latest information on current myositis studies being conducted by Corbus Pharmaceuticals, Orphazyme, Ra Pharma and CSL.
